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ABSTRACT 
BACKGROUND: Advanced glycation end-products (AGEs) are the final products derived from the 
nonenzymatic glycation process. AGEs are involved in the development of several health complications 
associated with diabetes and aging. Searching for anti- AGE extracts is necessary to mitigate the effects 
of age-related pathologies. 
RESULTS: The antioxidant and antiglycative activities of eight aqueous extracts of fruit and vegetable 
seeds were evaluated. All seed extracts (3.6 mg mL−1) exhibited anti-AGE activity in protein–glucose 
assay, ranging from 20 to 92% inhibition compared with aminoguanidine (4.87 mmol L−1). Green pepper 
extract exerted the highest anti-AGE activity. However, peach and pomegranate extracts exhibited the 
highest anti-AGE activity in protein–methylglyoxal assay, ranging from 0 to 79% inhibition. Hazelnut, 
almond and sesame extracts were not effective when methylglyoxal was the promoter. Apricot and 
peach extracts appeared to inhibit the formation of AGEs through their capacity for direct trapping of 
1,2-dicarbonyls (IC50=0.14 mg mL−1). No relationship between antioxidant and phenolic compound 
content and antiglycative activity was found. Therefore other hydrophilic constituents in addition to 
phenolic acids must be involved in the antiglycative activity of the extracts. 
CONCLUSION: Aqueous extracts of fruits and vegetables can be considered in the prevention of 
glycation-associated complications of age-related pathologies. 
 
KEYWORDS: advanced glycation end-products (AGEs); seed extract; glycation; glycation inhibitors; 
phenolic compounds 
 
INTRODUCTION 
The Maillard reaction or non-enzymatic glycation process is produced by the interaction between 
reducing sugars and free amino groups of proteins, lipids and nucleic acids. In the human body the final 
products that derive from this reaction are called advanced glycation end-products (AGEs). AGEs are a 
group of complex and heterogeneous products that can be classified according to their structures and 
characteristics as fluorescent crosslinking AGEs such as pentosidine, non-fluorescent crosslinking AGEs 
such as methylglyoxal–lysine dimer (MOLD) and non-crosslinking AGEs such as carboxymethyllysine 
(CML) and pyrraline.1 
 
It is known that AGEs are involved in the development of several health disorders such as diabetes and 
its complications,2 atherosclerosis,3 Alzheimer’s disease and normal aging.4 For this reason, the search 
for AGE formation inhibitors has recently received much attention.5–8 Various AGE inhibitors have 
been developed in the last few years, which can be divided into three groups: (1) inhibitors that prevent 
glycoxidation through metal ion chelation; (2) 1,2-dicarbonyl-trapping agents; (3) crosslink breakers.9 
Several AGE inhibitors have been described, a few of them exerting their effects at the early stage of 
glycation but most of them preventing the formation of AGEs at the late stage of glycation. Inhibition 
can occur through interference with the initial attachment between reducing sugars and amino groups, 
through trapping of carbonyls and radicals formed during glycation or through blocking the formation of 
intermediate Amadori products.10 Aminoguanidine (AG) and pyridoxamine (PM) are well-known AGE 
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inhibitors, both being considered as potent carbonyl scavengers. However, although such synthetic 
compounds have proved to be strong AGE inhibitors, they have also been associated with several 
adverse effects in in vivo assays.11,12 Therefore the search for natural products with the ability to 
inhibit AGE formation is currently being widely pursued. 
 
Many plant extracts have been evaluated for their inhibitory effects on the formation of AGEs, both 
through preventing glycoxidation and by scavenging reactive 1,2-dicarbonyls such as methylglyoxal 
(MGO), which are important precursors of AGEs.6,13,14 Most studies have been carried out in 
methanolic, ethanolic or other organic solvents,7,13,15 since the inhibitory effects are mainly attributed 
to polyphenols owing to their potent antioxidant activities.16 It is known that phenolic compounds 
possess strong antioxidant abilities as a result of their redox properties; moreover, it has been reported 
that such antioxidant effects might contribute to the inhibition of protein modifications in the glycation 
process.17 Among these studies, only a few have evaluated aqueous extracts of samples.18,19. 
 
In this regard, the aim of the present study was to investigate the inhibitory effects on AGE formation of 
aqueous extracts from eight different fruit and vegetable seeds considered as secondary by-products in 
the industry. For this purpose, different in vitro models of AGEs induced by glucose and MGO were 
evaluated. Samples were extracted in water, since, despite the fact that the antiglycative effect of 
aqueous extracts might be lower than that of organic solvent extracts, the extraction procedure is both 
more economical and environmentally friendly and therefore would be of greater interest for industrial 
applications. The extracts were also tested for their capacity in direct trapping of MGO. Moreover, 
antioxidant activity and phenolic compound content were examined in order to study their possible 
relationship with AGE-inhibitory activity. 
 
MATERIALS AND METHODS 
 
Commercially available fruit and vegetable seeds (green pepper, apricot, hazelnut, peach, sour cherry, 
sesame, almond and pomegranate) were provided by TIKTA (Ankara, Turkey). Detailed information on 
the different samples is listed in Table 1. D(+)-Glucose, bovine serum albumin (BSA), 400 g L−1 
methylglyoxal solution (MGO), sodium azide, aminoguanidine (AG), 5-methylquinoxaline (5-MQ), o-
phenyldiamine (OPD), gallic acid, Trolox, fluorescein and phenolic acid standards were purchased from 
Sigma (St Louis, MO, USA). Sodium dihydrogen phosphate monohydrate, glacial acetic acid, formic acid 
and high-performance liquid chromatography (HPLC)-grade methanol were acquired from Merck 
(Darmstadt, Germany). Folin–Ciocalteu reagent and sodium carbonate were obtained from Panreac 
Quimica (Barcelona, Spain). 2,2- Azobis(methylpropionamidine)dihydro (AAPH) and pyridoxamine (PM) 
were purchased from Fluka Chemical (Madrid, Spain). A Pierce bicinchoninic acid (BCA) protein assay 
kit was obtained from Thermo Scientific (Rockford, IL, USA). The Milli-Q water used was produced 
using an Elix3 water purification system coupled to an Advantage10 Milli-Q module (Millipore, Molsheim, 
France). All other chemicals and reagents were of analytical grade. 
 
Preparation of seed extracts 
Powder (500 mg) of each seed sample was extracted in water (25 mL × 2) at 50 ◦C by agitation for 10 
min each time. Pellets of the extracts were removed by centrifugation (1400 × g) and supernatants were 
collected, lyophilised and weighed. Soluble extracts were coded as described in Table 1. 
 
Measurement of pH 
Each lyophilised extract (250 mg) was mixed with 10 mL of water and vortexed for 3min. The mixture 
was held at room temperature for 1 h to separate solid and liquid phases. After carefully removing the 
supernatant layer, the pH was measured using a CG-837 pH meter (Schott, Mainz, Germany).  
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Determination of soluble protein 
Soluble protein measurements were performed using a modified BCA protein assay.20 According to 
Thermo Scientific, BCA protein assay reagent A contains sodium carbonate, sodium bicarbonate, BCA 
and sodium tartrate in 0.1 mL L−1 sodium hydroxide, while reagent B contains 40 g L−1 cupric sulfate. 
BCA working reagent was prepared by mixing 50 parts of reagent A and one part of reagent B. For 
sample analysis, 10 mg of lyophilised extract was dissolved in 1 mL of phosphate buffer (0.1 mol L−1, pH 
7.4) and vortexed for 10 min. The mixture was held at room temperature for 1 h and centrifuged at 
8000 × g for 10 min. A 50 μL aliquot of the supernatant was mixed with 500 μL of BCA working 
reagent. After incubation for 90 min at 37 ◦C, the absorbance at 562 nm was recorded using a 
-multimode microplate spectrophotometer (BioTek Instruments, Winooski, VT, USA) and 
 software was used. The limit of 
quantification was set at 5.15 mg g−1 sample. 
 
Determination of reducing sugars 
Reducing sugars were determined according to the method described by Miller.21 A calibration curve 
was constructed using standard glucose solutions in the concentration range 0.25–2 mg mL−1. Each 
lyophilised extract (50 mg) was suspended in 5 mL of distilled water at 50 ◦C, vortexed for 20 min and 
centrifuged at 1400 × g for 15 min at 4 ◦C. The supernatant was collected. The extraction was repeated 
twice and the supernatants were pooled. Following treatment with Carrez-I and Carrez-II solutions, the 
supernatant was used to determine reducing sugars after blank correction. Results were expressed as 
mg glucose equivalent g−1 sample. The limit of quantification was set at 25.2 mg glucose equivalent g−1 
sample. 
 
Determination of total phenolic content 
Total phenolic content (TPC) in the extracts was determined by the Folin–Ciocalteu method as 
described by Singleton et al.22 and adapted to a plate reader. Each lyophilised extract was dissolved in 
water to obtain a 10 mg mL−1 solution. In a 1.5 mL Eppendorf microtube, 100 μL of sample 
(appropriately diluted if necessary) and 250 μL of Folin–Ciocalteu reagent (diluted 1:1 (v/v) in methanol) 
were mixed and vortexed. After exactly 3min, 500 μL of 75gL−1 sodium carbonate solution and 4mLof 
methanol/water (50:50 v/v) were added, then the mixture was vortexed for a further 10 min and 
allowed to stand at room temperature in darkness for 60 min. The absorbance at 750 nm was recorded 
using a BioTek microplate spectrophotometer as described above and quantified using gallic acid as a 
standard. Results were expressed asmg gallic acid equivalent (GAE) g−1 sample. The limit of 
quantification was set at 4.5mgGAE g−1 sample. 
 
Determination of total extracted phenolic acids 
Total extracted phenolic acids were determined according to the method described by Kim et al.23 and 
Ross et al.24 First, 1 mL of 2 mol L−1 sodium hydroxide containing 13.4 mmol L−1 
ethylenediaminetetraacetic acid (EDTA) and 20 mL L−1 ascorbic acid was added to 30 mg of each 
lyophilised extract. The mixture was flushed with nitrogen and allowed to hydrolyse under agitation for 
16hat room temperature. After hydrolysis, the sample was centrifuged at 2370×g for 10 min at 4 ◦C and 
the supernatant wasacidifiedbyadding0.3mLof acetic acid. The liberated phenolic acids were extracted 
with ethyl acetate (2 × 2 mL). The organic layer containing the phenolic acids liberated by base 
hydrolysis was collected by pipetting off the upper organic (supernatant) layer from the bottom aqueous 
residue layer. The two organic layers were combined and evaporated to dryness in a speed-vac for 1 h 
at 45 ◦C. The residue was dissolved in 1mL ofmethanol/water (75:25 v/v) and filtered through a 0.45 μm 
filter, then the sample was analysed by HPLC. Quantification was conducted with a Shimadzu HPLC 
system (Kyoto, Japan) equipped with an LC-20AD pump, an SIL-10ADvp autosampler, a CTO-10ASVP 
oven and an SPD-M20A diode array detector. Chromatographic separation was carried out on a 
Kinetex C-18 100 °A column (100 mm × 4.6 mm, 2.6 μm; Phenomenex, Torrance, CA, USA). The flow 
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rate was 0.6 mL min−1 and the injection volume was 5 μL. The mobile phase consisted of 1mL L−1 
formic acid in water (solvent A) andmethanol (solvent B) and the gradient program was as follows: 0 
min, 25% B; 0–5 min, 25–30% B; 5–10 min, 30–60% B; 10–12 min, 60% B; 12–13 min, 60–80% B; 13–14 
min, 80% B; 14–15 min, 80–25% B; 15–18 min, 25% B. The total run time was 18 min and 
chromatograms were analysed at 254, 280 and 325 nm. The following phenolic acids were identified: p-
hydroxybenzoic acid (PHB), syringic acid (SYN), vanillic acid (VA), p-coumaric acid (pCU), caffeic acid 
(CA), ferulic acid (FA), protocatechuic acid (PCA), gallic acid (GA), gentisic acid (GE), sinapinic acid 
(SIN) and ellagic acid (EA). The limit of quantification was set at 2 μg g−1 sample. 
 
Determination of benzoic acids 
The presence of benzoic acids was determined using the HPLC method described by Lamuela-Raventos 
and Waterhouse.25 Procedures for sample preparation, quantification and chromatographic separation 
were the same as those described for total extracted phenolic acid determination. The total run time 
was 18 min and quantification was made at 280 nm (expressed as gallic acid). The limit of quantification 
was set at 2.5 μg GAE g−1 sample. 
 
Determination of flavonoids 
Flavonoid content was determined using the aluminium chloride method described by Abdel-Hameed.26 
Each lyophilised extract was dissolved in water at 25 mg mL−1. Then 80 μL of sample was mixed with 
80 μL of aluminium trichloride in ethanol and 100 μL of sodium acetate. The mixture was incubated in 
darkness for 90 min and centrifuged at 14 926 × g for 3 min. Flavonoids were determined based on the 
formation of a flavonoid–aluminium complex with absorptivity maximum at 440 nm. Absorbance 
readings were taken using aBioTek microplate spectrophotometer as described above. Quercetin was 
used as a reference standard. Results were expressed as μg quercetin equivalent per 100 g sample. The 
limit of quantification was set at 0.02 μg quercetin equivalent per 100 g sample. 
 
ORAC assay 
Alkylperoxyl free radical (ROO•)-scavenging activity was measured by monitoring the fluorescence 
decay due to ROO-induced oxidation of fluorescein, known as the oxygen radical absorbance capacity 
(ORAC) assay. The water-soluble azo initiator AAPH was applied as a clean and controllable source of 
thermally produced ROO• in aqueous media. ROO• were generated by AAPH in a microplate reader at 
37 ◦C. The antiradical activity against AAPH was estimated according to the procedure reported by 
D´avalos -multimode microplate reader with automatic reagent 
dispense and temperature control was used. All reaction mixtures were prepared in duplicate and four 
independent assays were performed for each sample. Raw data were processed by the microplate 
reader, and the area under the curve (AUC) was calculated. ORAC was expressed as Trolox equivalent 
antioxidant capacity (TEAC) using a standard curve constructed for each assay. Results were expressed 
as μmol TEAC g−1 sample. The limit of quantification was set at 18.1 μmol TEAC g−1 sample. 
 
ABTS assay 
Antioxidant activity was estimated in terms of the radical scavenging activity of samples in aqueous 
media following the procedure described by Delgado-Andrade and Morales28 with slight modification. 
2,2 -Azino-bis(3-ethylbenzothiazoline-6-sulfonic) acid radical cations (ABTS•+) were produced by 
reacting 7 mmol L−1 ABTS stock solution with 2.45 mmol L−1 potassium persulfate and allowing the 
mixture to stand in the dark at room temperature for 12–16 h before use. The ABTS•+ solution (stable 
for 2 days) was diluted with distilled water to an absorbance of 0.70 ± 0.02 at 734 nm. Each lyophilised 
extract was dissolved in water at 10 mg mL−1. Following the addition of 40 μL of sample (appropriately 
diluted if necessary) and Trolox standard to200μL of water and 40 μL of diluted ABTS•+ solution, an 
absorbance reading was taken after 10 min using a Bio- -multimode microplate reader 
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as described above. Aqueous solutions of Trolox at concentrations of 0.016–0.5mmolL−1 were used for 
calibration. The limit of quantification was set at 1.1 μmol TEAC g−1 sample. 
 
In vitro glycation assay with BSA–glucose 
The BSA–glucose (Glc) assay was based on Peng et al.6 and was used as an in vitro model for 
comparison of the antiglycation activities of the different seed extracts. First, BSA (35mgmL−1) and Glc 
(175 mg mL−1) were dissolved separately in phosphate buffer (0.1 mol L−1, pH 7.4). Then 200 μL of 
BSA solution containing 0.1 g mL−1 sodium azide (to ensure aseptic conditions) was incubated with 400 
μL of Glc solution at 37 ◦C for 21 days in the absence or presence of seed extract solutions (100 μL, 25 
mg mL−1). Blanks containing BSA–Glc but no test sample were kept at −80 ◦C until measurement. A 4 
mg mL−1 solution of AG (32.49 mmol L−1) was used as positive control, corresponding to 4.87 mmol 
L−1 in the reaction media. In parallel, seed extracts dissolved in phosphate buffer (0.1 mol L−1, pH 7.4) 
were incubated at 37 ◦C for 21 days in order to measure their intrinsic fluorescence. The final 
concentration of each reactant in the reaction medium was 10 mg mL−1 for BSA, 100 mg mL−1 for Glc, 
0.6 mg mL−1 for AG and 3.6 mg mL−1 for seed extracts. 
 
In vitro glycation assay with BSA–MGO 
The BSA–MGO assay was performed according to the method described by Lunceford and Gugliucci29 
with slight modification and was used to evaluate the inhibitory effects of the different seed extracts on 
protein glycation induced by MGO. First, BSA (35 mg mL−1) and MGO (0.4 mg mL−1) were dissolved 
separately in 
phosphate buffer (0.1 mol L−1, pH7.4). Then 200 μL of BSA solution containing 0.1 g mL−1 sodium 
azide (to ensure aseptic conditions) was incubated with 400 μL ofMGO solution at 37 ◦C for 14 days in 
the absence or presence of seed extracts solutions (100 μL, 25 mg mL−1). Blanks containing BSA–MGO 
but no test sample were kept at −80 ◦C until measurement. A 4 mg mL−1 solution of AG (32.49 mmol 
L−1) was used as positive control, corresponding to 4.87 mmol L−1 in the reactionmedia. In parallel, 
seed extracts dissolved in phosphate buffer (0.1 mol L−1, pH 7.4) were incubated at 37 ◦C for 14 days in 
order to measure their intrinsic fluorescence. The final concentration of each reactant in the reaction 
medium was 10 mg mL−1 for BSA, 0.23 mg mL−1 for MGO, 0.6 mg mL−1 for AG and 3.6 mg mL−1 for 
seed extracts. 
 
AGE fluorescence measurement 
Measurements of the fluorescent intensity of total AGEs and the intrinsic fluorescence of the different 
seed extracts after incubation were performed using a BioTek microplate spectrophotometer as 
described above. The presence of total AGEs was characterized by typical fluorescence with respective 
excitation and emission maxima at 360 and 420 nm for the BSA–Glc assay and 340 and 420 nm for the 
BSA–MGO assay. The percentage inhibition of AGE formation by each extract was calculated using the 
following equation: inhibition (%)={1−[(fluorescence of solution with inhibitor − intrinsic fluorescence of 
sample)/fluorescence of solution without inhibitor]} × 100. 
Evaluation of direct MGO-trapping capacity 
Direct MGO-trapping capacity was tested using the method described by Peng et al.15 with slight 
modification. MGO (0.4 mg mL−1) was dissolved in phosphate buffer (0.1 mol L−1, pH 7.4), OPD 
(derivatisation agent, 10.8 mg mL−1) was dissolved in methanol and 5-MQ (internal standard, 1 mg 
mL−1) was dissolved in 500 mL L−1 methanol. PM solution (1 mg mL−1 in 0.1 mol L−1 phosphate 
buffer, pH 7.4) was used as positive control. A 100 μL aliquot of MGO solution was mixed with 750 μL 
of phosphate buffered saline (PBS), 50 μL of 5-MQ and 100 μL of either PBS (blank), seed extract 
solutions (0.005–10mgmL−1) or PM solution. Therefore the final concentration of each reactant in the 
reaction medium was 0.04 mg mL−1 for MGO, 0.1 mg mL−1 for PM and 0.0005–1 mg mL−1 for seed 
extracts. After mixing, samples were incubated at 37 ◦C for 168 h. Then controls and samples were 
taken out, 200 μL of OPD was added and each mixture was shaken by vortex for 5 s. After 30 min 
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(when the derivatisation reaction was complete) the residual MGO was quantified on the basis of the 
amount of the derivatised product 2-methylquinoxaline (2- MQ) formed in each sample. Quantification 
was conducted using a Shimadzu HPLC system equipped with an LC-20AD pump, an SIL-10ADvp 
autosampler, a CTO-10ASVP oven and an SPD-M20A diode array detector. Chromatographic 
separation was carried out on a Mediterranea-Sea-ODS2 column (150 mm × 3 mm, 5 μm; 
Tecknokroma, Barcelona, Spain). The flow rate was 0.5 mL min−1 and the injection volume was 10 μL. 
Isocratic elution was applied using a mobile phase of 5mL L−1 acetic acid/methanol (50:50 v/v). The total 
run time was 7 min and chromatograms were recorded at 315 nm. The amount of unreacted MGO in 
each sample could be determined on the basis of the ratio of peak areas of 2-MQ and 5-MQ. The 
percentage decrease in MGO was calculated using the following equation: MGO decrease (%)=[(amount 
of MGO in control − amount of MGO in sample with tested seed extract solution or PM 
solution)/amount of MGO in control] × 100%. IC50 values of samples were evaluated from the dose–
response curves of each experiment using Microsoft Excel. 
 
Statistical analysis 
Statistical analyses were performed using Statgraphics Centurion XV (Herndon, VA, USA). Data were 
expressed as mean ± standard deviation (SD). Analysis of variance (ANOVA) and the least significant 
difference (LSD) test were applied to determine differences between means. Differences were 
considered to be significant at P < 0.05. Relationships between the different parameters analysed were 
evaluated by computing Pearson linear correlation coefficients at the P < 0.05 confidence level. 
 
RESULTS AND DISCUSSION 
As a first step, the solubility of each extract was evaluated. The extracts showed a wide range of 
solubility varying from from 129.8 to 478.1mg g−1,with pomegranate and green pepper seeds being least 
soluble and peach, apricot and almond seeds being most soluble (Table 1). Similarly, a wide variability in 
the pH of the extracts was observed when the lyophilised samples were reconstituted in water at a 
concentration of 25 mg mL−1, ranging from pH 4.0 for green pepper extract to pH 8.5 for pomegranate 
extract (Table 2). 
 
Since sugars and proteins are reactants of the Maillard reaction and may be involved in the glycation 
process, reducing sugars and soluble proteins were analysed in the aqueous extracts. The highest 
reducing sugar content was observed in sour cherry extract (201.1 mg g−1), followed by peach 
(136.1mg g−1) and sesame (124.0mg g−1) extracts, while almond and hazelnut extracts exhibited the 
lowest values (41.5 and 34.4mg g−1 respectively). Soluble protein content varied from 139.7 mg g−1 in 
sesame extract to 383.3 mg g−1 in hazelnut extract (Table 2). 
 
The antioxidant activities of the aqueous extracts were assessed by two methods: the ORAC assay and 
the ABTS assay (free radical-scavenging capacity). Table 2 shows the analytical results. The capacity to 
scavenge O2 − radicals ranged from 107.4 μmol TEAC g−1 extract for peach to 6378 μmol TEAC g−1 
extract for pomegranate, a huge difference. Similarly, the ABTS results varied markedly, ranging from 4.6 
to 232.7 μmol TEAC g−1 extract. Pomegranate extract had the highest free radical-scavenging activity, 
followed by green pepper extract, while sour cherry and apricot extracts showed the lowest scavenging 
activity. No significant correlation was found between ORAC and ABTS, but the capacity of certain 
extracts such as those of pomegranate and green pepper to scavenge O2− radicals was related to their 
capacity to scavenge ABTS radicals. 
 
Since phenolic compounds have been proposed as major contributors to antiglycative activity,6 they 
were also determined (Table 2). TPC varied from 4.8 mg GAE g−1 in apricot extract to 22.2 mg GAE 
g−1 in pomegranate extract. The proportion of individual phenolic acids in the total extracted phenolic 
acids was also evaluated (Table 3). Among these phenolic acids, one can note the significant 
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contributions of caffeic acid in apricot extract (41.3%), ferulic acid in sesame extract (39.9%) and gallic 
acid in pomegranate extract (39.8%). 
 
With the aim of finding other compounds present in the extracts that may be involved in antiglycative 
activity, benzoic acids and flavonoids were also determined. Benzoic acid content ranged from 3.5 to 7.9 
mg GAE g−1 extract, with almond and pomegranate extracts having the lowest and highest content 
respectively (data not shown). Flavonoid content was lower than the limit of quantification (0.02 μg 
quercetin equivalent per 100 g sample) for all extracts except that of pomegranate, whose content was 
0.29 μg quercetin equivalent per 100 g sample (data not shown). 
 
In order to evaluate the inhibitory effect of seed extracts against AGE formation in vitro, the 
fluorescence intensity was measured using AG as an AGE inhibitor. Figures 1A and 1B display the 
inhibitory effects at 25 mg mL−1 on AGE formation in BSA–Glc and BSA–MGO assays respectively (final 
concentration in reaction medium3.6mgmL−1). The results indicated significant differences in AGE-
inhibitory activity among most samples (P < 0.05). In BSA–Glc assay the AGE-inhibitory rate ranged 
from 20.7 to 91.9%. Green pepper exhibited the highest inhibitory capacity with a value close to the 
effect of AG solution (average inhibitory  rate 92.7%), followed by sesame and pomegranatewith 66.1 
and 61.7% inhibition respectively. The lowest inhibitory activity was observed for peach and apricot with 
20.7 and 23.2% inhibition respectively. In contrast, both peach and apricot, together with pomegranate, 
resulted inmorethan60%reduction intheformation offluorescent AGEs in BSA–MGO assay, whereas 
sesame, hazelnut and almond had no inhibitory activity. In this assay the AGE-inhibitory rate of seed 
extracts ranged from 0 to 78.6%, with the highest values being lower than the effect of AG solution 
(average inhibitory rate 99.2%). 
 
Several inhibitors can suppress AGE formation by scavenging certain precursors such as 1,2-dicarbonyls. 
An evaluation of direct MGO-trapping capacity was carried out in order to observe whether our tested 
seed extracts could directly scavenge these compounds. Figure 2 shows the different trapping abilities of 
the samples. All aqueous extracts trapped MGO in a dose-dependent manner and, with the exception of 
hazelnut and sesame, their activity at a concentration of 10 mg mL−1 was comparable to or higher than 
the effect of 1 mg mL−1 PM solution (99.6%). The values for IC50 (mg mL−1) are presented in Table 4. 
As can be observed, apricot and peach had the lowest IC50 (0.14 mg mL−1), followed by sour cherry 
(0.48 mg mL−1), associated with their high MGO-trapping capacity. In contrast, sesame and hazelnut had 
the highest IC50, corresponding to their low MGO trapping capacity (Fig. 2). As expected, IC50 from 
MGO-trapping assay was negatively correlated with antiglycative activity from BSA–MGO assay 
(r=−0.890, P=0.003). In this sense, peach and apricot exhibited the lowestIC50 by MGO-trapping assay 
and, at the same time, the highest antiglycative activity by BSA–MGO assay together with pomegranate. 
In contrast, no relation was found for pomegranate between IC50 from MGO-trapping assay and 
antiglycative activity from BSA–MGO assay. Regarding BSA–Glc assay, no relationship was found 
between IC50 and anti-AGE capacity according to this assay (P > 0.05). 
 
In the present study it has been demonstrated that aqueous extracts of fruit and vegetable seeds possess 
antiglycative activity. In addition, the samples displayed concentration-dependent MGO-trapping ability. 
However, as mentioned above, some of the extracts were found to be inhibitors of AGE formation in 
BSA–Glc assay, whereas little or no effect was observed when these samples were subjected to BSA–
MGO assay (Fig. 1). Since inhibitors of glycation can act in multiple steps, it is important to apply 
different scenarios such as BSA–Glc and BSA–MGO assays to reach a conclusion on their anti-AGE 
ability. Consequently, both positive and negative inhibitory effects should not be discounted. 
 
In previous studies, several authors have found correlations between TPC and the inhibitory effect on 
AGE formation of different extracts.6,7 The possible association of AGE inhibition and antioxidant 
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activity was analysed in our assays. No correlation between ORAC or ABTS and antiglycative activity 
was found in either BSA–Glc or BSA–MGO assay. Regarding the phenolic compound content, it was not 
correlated with anti-AGE activity in either absolute or relative amounts. Similar results have been 
observed by Povichit et al.,13 who reported that extracts of certain medicinal plants exhibited high 
antiglycative activity although they had low phenolic content. In accordance with Sun et al.,7 such 
absence of correlation suggests that phenolic compounds are not the sole antiglycative agents of the 
selected seed extracts and therefore other compounds present in the samples must be involved in their 
anti-AGE ability. It should be taken into account 
that most authors have investigated the preventive effect on AGE formation through extraction of 
samples with various organic solvents, which are more efficient than water for extracting phenolic 
compounds.30 As mentioned above, we carried out our assays using aqueous extracts, which might 
justify the lack of relationship between phenolic composition and antiglycative activity of the extracts. 
 
Another factor to consider is the individual phenolic acid composition in the different aqueous extracts. 
In this sense, Wu et al.31 evaluated the ability of dietary phenolic acids to inhibit glucose-mediated 
protein glycation. The authors concluded that at a concentration of 1 mmol L−1 most phenolic acids 
inhibited the glycation process, with vanillic, gallic and ferulic acids being the most significant inhibitors. 
According to these results, the high inhibitory activity of sesame and pomegranate in BSA–Glc assay 
could be explained, as their major phenolic acids were ferulic acid and gallic acid respectively (Table 3, 
Fig. 1A). Recently, Muthenna et al.32 reported ellagic acid to be a potent antiglycating agent in a 
protein–sugar system, which, together with gallic acid, could explain the high antiglycative activity of 
pomegranate extract. Regarding green pepper, its anti-AGE ability in this system could be associated 
mainly with its ellagic acid content, but in addition with its ferulic acid and phydroxybenzoic acid 
content, which, although at lower intensity, has also been found to be an antiglycative agent.31 The anti- 
AGE effect of the compounds, however, depends on the tested concentrations; thus low, high or no 
antiglycative activity has been described for ferulic acid at different incubation conditions in protein–
sugar model systems.19,33,34 In the BSA–MGO system, Gugliucci et al.35 reported high AGE inhibition 
by caffeic acid. This may justify apricot extract showing on eof the highest antiglycative activities in the 
present study (Fig. 1B), but it does not justify pomegranate or peach extract activity. It should be 
highlighted that, in accordance with Chompoo et al.,5 the presence of more than one inhibitor in an 
extractmayhave a synergistic effect. In this way, Rice-Evans et al.36 reported that phenolic compounds 
may have antagonistic or synergistic effects with themselves or with other constituents of a sample, 
which may justify the diversity found among the results of the present study. To the best of our 
knowledge, antiglycative effects of sesame, green pepper, apricot andpeach seeds have not been 
reportedbefore. Regarding pomegranate seed, anti-glycative ability associated with its free radical-
scavenging property has been reported by Rout and Banerjee.37 
 
CONCLUSIONS 
Eight aqueous extracts of fruit and vegetable seeds were evaluated for their antiglycative activity using 
different in vitro models. All extracts exhibited positive inhibitory effects on the formation of AGEs in 
BSA–Glc assay, although to different extents. However, BSA–MGO assay and direct MGO-trapping 
assay showed that some extracts exerted their activity through a different mechanism of action. 
Aqueous extracts of peach, pomegranate and apricot seeds appeared to inhibit the formation of AGEs 
through their capacity for trapping 1,2-dicarbonyls. These findings are relevant for focusing on potential 
extracts to combat the main promoters of aging in humans. On the other hand, no relationship between 
antioxidant and phenolic compound content and antiglycative activity of the extracts was found. This 
finding leads us to conclude that other hydrophilic constituents in addition to phenolic acids must be 
involved in the antiglycative activity of the aqueous seed extracts. Isolation and characterisation of 
different target compounds are undercurrent investigation by advanced structural identification 
methodologies. 
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FIGURES AND TABLES 
 
Table 1 
Description of the tested seed samples and their solubility in water. 
a
 
Sample 
extract ID 
Common name Scientific name Family Soluble extract 
       (mg g
-1
) 
Gp Green pepper Capsicum annuum Solanaceae 194.9 ± 0.64b 
Ap Apricot Prunus armeniaca Rosaceae 445.8 ± 22.27de 
Ha Hazelnut Corylus avellana Betulaceae 436.2 ± 17.04d 
Pe Peach Prunus persica Rosaceae 478.1 ± 16.05e 
Sc Sour cherry Prunus cerasus Rosaceae 257.1 ± 29.27c 
Se Sesame Sesamum indicum Pedaliaceae 224.6 ± 8.06bc 
Al Almond Prunus dulcis Rosaceae 442.8 ± 15.77de 
Po Pomegranate Punica granatum Punicaceae 129.8 ± 4.31a 
a Results are expressed as mean ± SD for n = 3. Different letters mean significant differences (p < 0.05). 
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Table 2 
Characterization of the aqueous extracts from fruit and vegetable seeds. 
a
 
Sample 
extract 
pH Soluble protein 
(mg g
-1
) 
Reducing sugars 
(mg g
-1
) 
      ORAC 
(µmol TEAC g
-1
) 
      ABTS 
(µmol TEAC g
-1
) 
     TPC 
(mg GAE g
-1
) 
Gp 4.0   219.0 ± 10.3b     93.3 ± 2.75c  359.6 ± 5.16c    91.6 ± 35.4c 10.7 ± 0.3d 
Ap 4.5   282.0 ± 19.1cd     71.5 ± 0.67b  145.6 ± 6.36ab      8.9 ± 2.1a   4.8 ± 0.2a 
Ha 5.5   383.3 ± 42.3e     34.4 ± 0.30a  144.7 ± 2.83ab    17.3 ± 2.1ab 10.2 ± 0.8d 
Pe 5.5   209.0 ± 2.5b   136.1 ± 3.42e  107.4 ± 14.28a    10.4 ± 2.3a   8.8 ± 0.2c 
Sc 5.5   330.3 ± 28.5de   201.1 ± 5.29f  300.4 ± 0.35c      4.6 ± 1.6a   7.3 ± 0.7b 
Se 6.5   139.7 ± 8.3a   124.0 ± 0.01d  272.9 ± 2.55bc    42.7 ± 2.6b   7.8 ± 0.3bc 
Al 6.5   227.6 ± 0.9bc     41.5 ± 0.29a  124.7 ± 1.56a    24.3 ± 5.7ab 10.9 ± 0.1d 
Po 8.5   368.4 ± 39.8e   119.6 ± 0.79d   6378 ± 160.9d  232.7 ± 16.1d 22.2 ± 1.1e 
a Gp: green pepper. Ap: apricot. Ha: hazelnut. Pe: peach. Sc: sour cherry. Se: sesame. Al: almond. Po: pomegranate. 
Results are expressed as mean ± SD for n = 4. Different letters mean significant differences (p < 0.05). 
TPC: Total phenolic content. 
 
 Table 3 
Proportion of phenolic acids in each seed extract expressed as percentage. 
a
 
Sample extract PHB SYN VA pCU CA FA PCA GA GE SIN EA 
Gp 24.0 2.1 5.2 5.2 5.6 18.7 9.6 nd nd 5.1 24.4 
Ap 3.0 1.8 4.8 13.5 41.3 26.7 5.7 0.7 nd 2.5 nd 
Ha 5.6 10.4 32.0 4.7 1.2 3.2 22.2 15.4 nd 5.3 nd 
Pe 21.5 7.7 1.9 17.5 2.4 17.2 28.0 1.7 nd 2.0 nd 
Sc 20.1 3.5 1.1 16.3 20.8 3.3 14.7 4.1 12.2 4.0 nd 
Se 7.7 2.6 0.4 30.1 11.3 39.9 4.6 0.1 nd 3.3 nd 
Al 9.8 38.4 2.7 10.3 12.3 7.1 12.5 2.7 nd 4.3 nd 
Po 11.8 8.8 0.1 8.3 1.6 4.5 4.2 39.8 nd 1.3 19.6 
a Gp: green pepper. Ap: apricot. Ha: hazelnut. Pe: peach. Sc: sour cherry. Se: sesame. Al: almond. Po: pomegranate. 
PHB: p-hydroxybenzoic. SYN: syringic acid. VA: vanillic acid. pCU: p-coumaric. CA: caffeic acid. FA: ferulic acid. PCA: 
protocatechuic acid. GA: gallic acid. GE: gentisic acid. SIN: sinapinic acid. EA: ellagic acid. nd < 2 µg g-1 sample 
 
 
  
 Table 4 
MGO trapping capacity of the different seed extracts. 
a
 
Sample extract IC50 values (mg mL
-1
) 
Gp 1.70 
Ap 0.14 
Ha 3.30 
Pe 0.14 
Sc 0.48 
Se 2.65 
Al 2.25 
Po 1.60 
PM 0.06 
a Gp: green pepper. Ap: apricot. Ha: hazelnut. Pe: peach. Sc: sour cherry. 
Se: sesame. Al: almond. Po: pomegranate. PM: piridoxamine. 
  
 Figure captions 
 
Figure 1. (A): Antiglycative activity of the different seed extracts on the formation of AGEs in 
BSA-glucose (Glc) assay. (B): Antiglycative activity of the different seed extracts on the formation 
of AGEs in BSA-methylglyoxal (MGO) assay. The concentration of each extract was 25 mg mL-1 
(final concentration in the reaction medium 3.6 mg mL-1). Results are expressed as mean ± SD for 
n = 4. Different letters mean significant differences (p < 0.05). AG solution (final concentration 0.6 
mg mL-1) presented an antiglycative activity of 92.7% and 99.2% for BSA-Glc and BSA-MGO assays, 
respectively. Green pepper (Gp), apricot (Ap), hazelnut (Ha), peach (Pe), sour cherry (Sc), sesame 
(Se), almond (Al) and pomegranate (Po). 
 
Figure 2. Dose-dependent results for MGO trapping capacity experiment at 168 h of the 
different seed extracts. (A) MGO scavenging abilities of green pepper (Gp), apricot (Ap), sour 
cherry (Sc) and hazelnut (Ha). (B) MGO scavenging abilities of peach (Pe), sesame (Se), almond 
(Al) and pomegranate (Po). Results are expressed as mean ± SD for n = 4. PM solution (final 
concentration 0.1 mg mL-1) presented a MGO trapping capacity of 99.6%. 
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